(Q43845727)

27 November 2017

title

Olanzapine treatment for patients with schizophrenia and substance abuse (English)

1 reference

27 November 2017

1 reference

K H Littrell

1

1 reference

27 November 2017

R G Petty

2

1 reference

27 November 2017

N M Hilligoss

3

1 reference

27 November 2017

C D Peabody

4

1 reference

27 November 2017

C G Johnson

5

1 reference

27 November 2017

publication date

1 December 2001

1 reference

Journal of Substance Abuse Treatment

27 November 2017

published in

1 reference

27 November 2017

volume

21

1 reference

27 November 2017

issue

4

1 reference

27 November 2017

page(s)

217-221

1 reference

Decreased substance use in chronically psychotic patients treated with clozapine

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Self reports of the interaction between substance abuse and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

A rating scale for drug-induced akathisia

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Substance abuse in schizophrenia: service utilization and costs

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Exclusion criteria of DSM-III. A study of co-occurrence of hierarchy-free syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Depression in alcoholic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Olanzapine response in treatment-refractory schizophrenic patients with a history of substance abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Do atypical antipsychotic medications favorably alter the long-term course of schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Relationship between Concurrent Substance Abuse in Psychiatric Patients and Neuroleptic Dosage

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Abbreviated instrument to measure hope: development and psychometric evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Diagnosis and management of substance use disorders among inpatients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Substance use disorder and the early course of illness in schizophrenia and affective psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Prevalence and patterns of "dual diagnosis" among psychiatric inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Reduction of comorbid substance abuse with clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Olanzapine attenuates the reinforcing effects of cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Six-month outcomes for patients who switched to olanzapine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Medication noncompliance and substance abuse among patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Suppression of alcohol preference in rats induced by risperidone, a serotonin 5-HT2 and dopamine D2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Pharmacological treatment of substance-abusing schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900205-7

7 January 2021

10.1016/S0740-5472(01)00205-7

Identifiers

DOI

1 reference

27 November 2017

1 reference